MetaCap

Glaukos Statistics

NYSE: GKOSHealth CareMedical/Dental InstrumentsUSD

237.31-0.79 (-0.33%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Glaukos by the numbers

Glaukos has a market capitalization of $14.05 billion based on 59.20M shares outstanding. With trailing EPS of $-2.95, Glaukos is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 24.3% above its 50-day average and 57.9% above its 200-day average.

Average daily trading volume is 1.19M shares, or about $282.9 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

GKOS valuation vs. peer median

GKOS compared with the median of 8 peer companies
MetricGKOSPeer medianDifference
Market cap$14.05B$9.05B+55%
Forward P/E169.515.8+973%
Avg. volume1.19M912.52K+31%

Peer median across 8 companies: SOLV, BAX, PEN, PODD, GMED, TFX, HAE, MMSI.

Valuation

Market cap
$14.05B
Price / sales (latest FY)
27.68
EPS (TTM)
$-2.95

Price and trading

Previous close
238.10
Open
238.87
Day range
233.40 – 244.55
52-week range
93.96 – 255.19
52-week change
+138.22%
Beta
—
Volume
1.09M

Dividends and events

Annual dividend
None
Next earnings date
Oct 28, 2026

Additional statistics

Market Cap
14.05B
Forward Pe
169.50
Eps
-2.95
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
255.19
Week52 Low
93.96
Avg Volume
1.19M
Shares Outstanding
59.20M
Ma50
190.95
Ma200
150.33
Earnings Date
Oct 28, 2026
Pct From52w High
-7.00%
Pct From52w Low
152.56%

Related